Merck KGaA et al v. Accord Healthcare, Inc. et al
| Merck KGaA, Merck Serono SA and Ares Trading SA |
| Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd. |
| 1:2022cv00974 |
| July 25, 2022 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 22, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 17 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,947 B2 ;8,377,903 B2 ;10,849,919 B2 (Amended). (Tigan, Jeremy) |
| Filing 16 Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck KGaA for Ares Trading SA, Merck Serono SA filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (Tigan, Jeremy) |
| Filing 15 First AMENDED COMPLAINT against Accord Healthcare, Inc.- filed by Merck Serono SA, Merck KGaA, Ares Trading SA. (Attachments: #1 Exhibits A-D)(Tigan, Jeremy) |
| Filing 14 STIPULATION of Dismissal as to Defendant Intas Pharmaceuticals Ltd. (without prejudice) and Amending Caption to Reflect Same - by Merck KGaA, Merck Serono SA. (Tigan, Jeremy) |
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Gillian T. Farrell filed by Merck Serono SA, Merck KGaA. Signed by Judge Gregory B. Williams on 9/21/22. (ntl)
|
| Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Gillian T. Farrell - filed by Merck KGaA, Merck Serono SA. (Tigan, Jeremy) |
| Filing 12 NOTICE requesting Clerk to remove Stephanie Neely as co-counsel. Reason for request: No longer with firm. (Blumenfeld, Jack) |
| Case Reassigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 11 WAIVER OF SERVICE returned executed by Merck Serono SA, Merck KGaA: For Intas Pharmaceuticals Ltd. waiver sent on 8/2/2022, answer due 10/3/2022. (Blumenfeld, Jack) |
| Filing 10 WAIVER OF SERVICE returned executed by Merck Serono SA, Merck KGaA: For Accord Healthcare, Inc. waiver sent on 8/2/2022, answer due 10/3/2022. (Blumenfeld, Jack) |
| Filing 9 VAC Notice, Consent, Non-Consent, Magistrate Referral (etg) |
| Filing 8 ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 7/27/2022. (etg) |
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, Vinita Ferrera, Emily R. Whelan, Deric X. Geng, Stephanie Neely and Yang Li - filed by Merck KGaA, Merck Serono SA. (Blumenfeld, Jack) |
|
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, Vinita Ferrera, Emily R. Whelan, Deric X. Geng, Stephanie Neely and Yang Li filed by Merck Serono SA, Merck KGaA. Ordered by Judge Colm F. Connolly on 7/27/2022. (etg)
|
| Case Assigned to Vacant Judgeship (2022). Please include initials of VAC after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued as to Accord Healthcare, Inc. on 7/25/2022; Intas Pharmaceuticals Ltd. on 7/25/2022. (Attachments: #1 Summons Issued)(mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck KGaA for Merck Serono SA filed by Merck KGaA, Merck Serono SA. (mpb) |
| Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 14, 2022. Date of Expiration of Patent: 10/16/2022 & 12/14/2024.Thirty Month Stay Deadline: 12/14/2024. (mpb) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,947 B2 ;8,377,903 B2. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Ltd. ( Filing fee $ 402, receipt number ADEDC-3922104.) - filed by Merck Serono SA, Merck KGaA. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
